Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

President Trump is attempting to reshape America’s biotech industry with two primary objectives. He wants more medicines to ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

Down here in Louisiana, we’ve got enough financial worries, especially after four years of Biden-induced inflation. Yet, ...

Governor JB Pritzker joined Attorney General Kwame Raoul, healthcare advocates, independent pharmacists, and legislators to ...

President Donald Trump recently signed a new executive order advancing a “most favored nation” approach to drug pricing. The ...